Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Antibodies (Basel, Switzerland)|April 24, 2023
CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory DiseasesSara Gómez-Melero, Javier Caballero-VillarrasoJournal of Clinical Medicine|June 19, 2024
Impact of Cognitive Impairment on Quality of Life in Multiple Sclerosis Patients-A Comprehensive ReviewSara Gómez-Melero, Javier Caballero-Villarraso, Begoña Mª Escribano, et al.Frontiers in Immunology|March 17, 2025
Tandem CAR-T cell therapy: recent advances and current challengesSara Gómez-Melero, Fakhri Hassouneh, Isabel M Vallejo-Bermúdez, et al.Antioxidants (Basel, Switzerland)|October 26, 2024
One-Year Impact of Occupational Exposure to Polycyclic Aromatic Hydrocarbons on Sperm QualityMª Victoria Peña-García, Mª José Moyano-Gallego, Sara Gómez-Melero, et al.Stem Cells Translational Medicine|September 16, 2023
Preclinical Evidence for the Use of Oral Mesenchymal Stem Cell-Derived Extracellular Vesicles in Bone Regenerative Therapy: A Systematic ReviewAllinson Olaechea, Karim Benabdellah, Andrea Vergara-Buenaventura, et al.BMC Biotechnology|July 6, 2021
Amino terminal recognition by a CCR6 chemokine receptor antibody blocks CCL20 signaling and IL-17 expression via β-arrestinSara Gómez-Melero, Fé Isabel García-Maceira, Tania García-Maceira, et al.Biomedicines|February 25, 2022
Development of a High-Throughput Calcium Mobilization Assay for CCR6 Receptor Coupled to Hydrolase Activity ReadoutSara Gómez-Melero, Fé Isabel García-Maceira, Tania García-Maceira, et al.International Journal of Molecular Sciences|September 28, 2024
MIND Diet Impact on Multiple Sclerosis Patients: Biochemical Changes after Nutritional InterventionAinoa Navarrete-Pérez, Sara Gómez-Melero, Begoña Mª Escribano, et al.Pageof 1